It is important that further work is carried out on the CaSR and proliferation of VSMCs as although current available data may be variable, it does highlight the potential for CaSR therapeutics, whether calcimimetics and/or calcilytics, to reduce proliferation associated with cardiovascular disease. Here, CASR is linked to cardiovascular disorder.